Australia
Launch Amgen into Dermatology with Otezla for inflammatory skin disease (2019). Manage and grow the Nephrology portfolio, including a program launch, engaging all key stakeholders in hospital and private accounts. Launch of the recently broadened reimbursement of Evenity (Jan 2025). Key Achievements: - 2025 Chairman's Circle Winner, top 10% of sales. Highest growth national for Aranesp. Appointed a mentorship role for new hires. - 2024 Otezla 103% to target. - 2023 Promotion to Executive Biopharmaceutical Specialist. - 2022 Otezla brand champion and marketing project lead. Appointed role as FAB representative. - 2021 Otezla brand champion. Grew rural Aranesp M/S from 52%-60% within a 6 month period. - 2020 Otezla Launch
Specialising in pain management. Managing a pain portfolio across different specialist groups within NSW; Pain Physicians , Anaethetists, Oncologists, Orthopaedic Surgeons, Rehab Physician and Rheumatologists. Key Achievements: - 2017/2018 Worked closely with GP team to implement and successfully roll out meetings and GP education. Successfully ran more than 20 meetings. - 2017 National Sales Award for team work - 2016 Involved with submission of hospital formularies for all products - 2015 Promotion from NSW GP rep to a National Sales Executive position within the pain portfolio.
Promoted Prolia and Duodart to keep primary care practices, practice nurses and pharmacies. Key Achievements - 2014 Exceeded dollar target for my primary brand, Prolia. 121% to sales target. - 2011-2013 Organised all aspects of 14 launch product meetings.